A batch of drugs have applied for withdrawal of the standard and are not available

A batch of drugs have been withdrawn from the market and will not be sold in the whole province On November 26, Gansu public resources trading Bureau issued the notice on the application for withdrawal of waste drugs to cancel the qualification of winning the bid and hanging on the Internet (the 29th batch) 19 drugs from 15 pharmaceutical companies were unable to guarantee normal supply due to production line transformation, rising cost, shortage of raw materials, production suspension and other reasons, and applied for withdrawal of the bid From the batch marked in Gansu notice (the 29th batch), the number of times that some drugs have applied for withdrawal of form and abandoned label in Gansu has been relatively large In addition, according to cypress blue monitoring, this phenomenon also occurs in many provinces, most of which are based on the above-mentioned cost increases Is there any consideration other than cost when some drugs are withdrawn from a provincial market? In this regard, Zhang Bin, a senior pharmacist, said in an interview with cypress blue that the initiative of some drugs in a province to apply for the withdrawal of the bid and the cancellation of the bid may be price maintenance under the overall planning of the national market As for why this phenomenon appears more frequently, Zhang Bin once said that "we can change the overall situation at the expense of a small market share" According to the circulation report of the Ministry of Commerce in 2017, the total regional sales volume of Gansu Province ranks 28th among 31 provinces, cities and autonomous regions in the country, and the smaller market share is in line with the judgment basis of the insiders on the frequent bid abandonment of enterprises in Gansu In the interview, many medical people agreed with this view A marketing executive of a pharmaceutical enterprise told saibelan that if the enterprise had decided not to supply in this province, it would be better to withdraw silently and not to sell Why should it take the initiative to apply for the withdrawal of the bid and the cancellation of the price? The purpose behind this is obvious It may be to wipe out the national minimum price, the marketing executive said Guo Xinfeng, partner of Nanjing Leyao Venture Capital Management Co., Ltd., analyzed that in the past, the price of drug companies was hanging upside down, and they were biting their teeth to produce at a loss The purpose of withdrawing and scrapping the bid was to raise the price after the production was resumed However, Zhang Bin thinks that in fact, there is no way for enterprises to operate in this way It's just a way to take the two evils' rights lightly Otherwise, who is willing to give up the market easily? At present, most provinces require enterprises to declare the lowest price in five or ten provinces, and some provinces, such as Zhejiang Province, require the lowest price in China In this way, it can be understood that there are technical operation maintenance prices of enterprises In addition, it is also common for competitors to restrict each other with the price of the Internet At present, Zhang Bin said that the state's policy trend towards the industry is clear to all The direction the state should take is to enlarge the Sanming model It is normal for prices to go down all the way or even fall sharply, and enterprises know it Nowadays, many enterprises trade time for space, through such technical operations, in exchange for their own space, and do not want to be out of the game immediately Recently, many enterprises are optimizing their teams, or changing their own operation, transfer to other hospitals or even OTC market At present, the phenomenon of sacrificing the price of one place to protect the national market will not work once the whole country is playing chess, such as the national centralized purchase But there are also ways to make this phenomenon disappear, namely, purchasing with quantity Under the logic of purchasing with quantity, each province gets the price based on its own consumption and drug enterprise negotiation, which is naturally inconsistent Provinces do not have to contend with the price difference of the same drug in different provinces, and pharmaceutical companies do not have to worry about the price depression affecting other provinces In any case, price reduction is the trend A new round of centralized purchase aimed at squeezing out the high water content of drug prices may see the end of price reduction, which in the words of medical people is the end of price reduction Judging by this standard, the space for price reduction is likely to be compressed on the basis of current drug prices, in addition to ensuring the profit space of production enterprises and distribution enterprises At the same time, the volume procurement is not only led by the state, but also by the provinces, which will restructure the generic pharmaceutical market Today, Jiangxi Province held a press conference on the centralized purchase and use of drugs, which opened another province's belt purchase Guo Xinfeng believes that the local version of the 4 + 7 collection drama is about to debut, and the generic pharmaceutical industry is about to be generalized: the division of labor of the generic drug collection is clear, that is, the once-in-a-year 4 + 7 national centralized procurement led by the state health insurance bureau is for the generic drugs, while the once-in-a-year 4 + 7 regional procurement led by the provincial health insurance bureau is for the generic drugs, quickly squeezing out the price water of the generic drugs According to the rhythm of the simultaneous efforts of the state and local governments, the generic drug market will break out in the future and the price will rise At the same time, chronic diseases and basic drug market are about to break out With the continuous promotion of national 4 + 7, the increase of the proportion of basic drugs, the increase of outpatient chronic medicine allocation, and the increase of the penetration rate of chronic disease patients, the demand of chronic disease market will be blowout.